Maintenance Immunosuppressive Agents as Risk Factors for BK Virus Nephropathy: A Case-Control Study

Background. The specific role of different immunosuppressive agents as risk factors for BK virus nephropathy (BKN) has not been well studied. Methods. In this case-control study, we examined the association of tacrolimus (TAC), mycophenolate mofetil (MMF), and prednisone with BKN in renal allograft recipients transplanted between 1997 and 2004 at our center who underwent biopsies for allograft dysfunction. Drug levels or doses were recorded during the 3 months before the index biopsy. Random effects logistic modeling was used for data analysis. Results. There were 33 cases with BKN, biopsied at 16.4±2.8 months and 66 matched controls with biopsies at 21.5±2.1 months posttransplant (P=0.16). After adjusting for sex, race, retransplant status, diabetes, donor source, and induction agent, TAC blood level was associated with increased risk of BKN (odds ratio [OR] 1.3, 95% confidence interval [CI] 1.02-1.7, P=0.03), whereas MMF dose was not (OR 1.0, 95% CI 0.99-1.0, P=0.2). Moreover, prednisone dose was also found to be a significant risk factor for BKN (OR 1.22, 95% CI 1.04-1.4, P=0.02). Conclusions. The results of this study show that BKN is associated with TAC level and prednisone dose and not with MMF dose. This suggests that reducing TAC and prednisone dose and maintaining MMF may be a more appropriate initial approach for the treatment of BKN. Further studies are needed to compare the efficacy and safety of this approach with the currently recommended one.

[1]  M. Koukoulaki,et al.  Prospective monitoring of BK virus replication in renal transplant recipients , 2009, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  P. Acott,et al.  Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  V. Sharma,et al.  Epidemiology of BK Virus in Renal Allograft Recipients: Independent Risk Factors for BK Virus Replication , 2008, Transplantation.

[4]  R. Munivenkatappa,et al.  Polyomavirus BK Versus JC Replication and Nephropathy in Renal Transplant Recipients: A Prospective Evaluation , 2007, Transplantation.

[5]  T. Larson,et al.  Comparison of Low Versus High Tacrolimus Levels in Kidney Transplantation: Assessment of Efficacy by Protocol Biopsies , 2007, Transplantation.

[6]  D. Brennan,et al.  Erratum: Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction (American Journal of Transplantation (2005) 5 (582-594)) , 2005 .

[7]  M. Schnitzler,et al.  Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  A. Schwarz,et al.  Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  C. Drachenberg,et al.  Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients , 2003, Transplantation.

[10]  R. Stratta,et al.  Polyomavirus in kidney and kidney‐‐pancreas transplant recipients , 2003, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.

[12]  J. Fishman.  BK virus nephropathy--polyomavirus adding insult to injury. , 2002, The New England journal of medicine.

[13]  R. Alloway,et al.  Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. , 2002, Transplantation proceedings.

[14]  J. Fink,et al.  Clinical course of polyoma virus nephropathy in 67 renal transplant patients. , 2002, Journal of the American Society of Nephrology : JASN.

[15]  W. Knowles.  The Epidemiology of BK Virus and the Occurrence of Antigenic and Genomic Subtypes , 2002 .

[16]  G. Mazariegos,et al.  First Clinical Use of a Novel Bioartificial Liver Support System (BLSS) † , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  H. Hirsch.  Polyomavirus BK Nephropathy: A (Re‐)emerging Complication in Renal Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Colvin,et al.  BK virus in solid organ transplant recipients: an emerging syndrome. , 2001, Transplantation.

[19]  R. Colvin,et al.  Differential diagnosis between infection and rejection in renal allografts. , 2001, Transplantation proceedings.

[20]  A. Demetris,et al.  Nephropathy due to polyomavirus type BK. , 2000, The New England journal of medicine.

[21]  T. Klimkait,et al.  Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. , 2000, The New England journal of medicine.

[22]  J. Rochussen,et al.  THE INCREASED INCIDENCE OF BK POLYOMA VIRUS IN RENAL TRANSPLANT RECIPIENTS TREATED WITH PROGRAF®.: Abstract# 1051 , 2000 .

[23]  S. E. Miller,et al.  Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. , 1999, Transplantation.

[24]  J. Fink,et al.  Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. , 1999, Human pathology.

[25]  F. Gudat,et al.  Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. , 1999, Journal of the American Society of Nephrology : JASN.

[26]  F. Gudat,et al.  Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. , 1999, Transplantation.

[27]  S. Finkelstein,et al.  Human polyoma virus-associated interstitial nephritis in the allograft kidney. , 1999, Transplantation.

[28]  T. Yen,et al.  Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  A. Demetris,et al.  Human polyoma virus infection of renal allografts: histopathologic diagnosis, clinical significance, and literature review. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[30]  P. Randhawa,et al.  BK virus infection in a kidney allograft diagnosed by needle biopsy. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  C. Smith,et al.  Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. , 1984, Journal of clinical pathology.

[32]  E. Borden,et al.  Human polyomavirus infections with JC virus and BK virus in renal transplant patients. , 1980, Annals of internal medicine.

[33]  D. Coleman,et al.  New human papovavirus (B.K.) isolated from urine after renal transplantation. , 1971, Lancet.

[34]  T. Radford.  ON THE SOURCES OF HÆMORRHAGE IN CASES OF PLACENTA PRÆVIA, &c. , 1847 .

[35]  J. Steiger,et al.  Polyomavirus BK. , 2003, The Lancet. Infectious diseases.

[36]  J. Fink,et al.  BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. , 2002, Clinical transplants.

[37]  P. Harrison,et al.  Human polyoma virus (HPV)--a significant pathogen in renal transplantation. , 1978, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.